Tissue Engineering in Finland Today
AUGUST 26th, 2021 at 13:00-15:00 Helsinki summer time, EEST (UTC+3)
Did you miss our virtual event about the latest developments in tissue engineering in Finland?
A recording is now available.
You can also click on the headlines or buttons below to go directly to the presentation you like to view.
Share on social networks
Share on linkedin
Share on twitter
Share on facebook
AGENDA
| Andreas Slama |
| Andreas Slama |
SPEAKERS
Hongbo Zhang, PhD
Associate Professor in Åbo Akademi University
Guest Professor in Ruijin Hosptial, Shanghai Jiaotong University
Hongbo Zhang graduated his PhD from Faculty of Pharmacy, University of Helsinki in December 2012 and then he did three years postdoc in Harvard University supervised by Prof. David A. Weitz. He has a multidisciplinary background in pharmacy, nanotechnology, microfluidics, precision medication, bioimaging, diagnostics; and he knows the world leading technologies. In September 2016, he becomes a Tenure track Assistant Professor in Åbo Akademi University and established his own research group and he became Tenure track Associate Pofessor in November 2018. He has published 120 papers, with total impact factor of 1200+, google citation of 4500+, H-index of 41. He is reviewer of Chemical Reviewer, Advanced Materials, ACS Nano and many other journals. He has also been corresponding 14 research projects in Finland and in China. He is the co-founder of ChinFin Incubator and Innovation Oy, Turku, and in collaboration with Huaihai Rongtai Holding, they will focus on Biomedical research commercialization.
Seppo Vainio, PhD
professor developmental biology
group leader Infotec and Kvantum Institute in Oulu
PhD Seppo Vainio is a professor developmental biology, group leader in Infotech Oulu and also Kvantum Institute in Oulu University in the Faculty of Biochemistry and Molecular Medicine. He also serves as a vice director of the Academy of Finland GeneCellNano flagship. Vainio has published close to 170 articles that have been sited more then 13 000 time with H-index 56. The prime R&D focuses on programming and engineering mammalian organogenesis in part via the molecular/nanocommunication tools.
Virpi Muhonen, PhD
CEO Askel Healthcare
Chairman Tissue Cure Alliance Finland
Virpi Muhonen is the CEO and co-founder of Askel Healthcare Ltd, a Finnish medical device company dedicated to rebuilding cartilage tissue to prevent joint pain. She holds a doctorate in orthopaedic cell biology and after finishing her PhD studies, she worked as a Principal Investigator in the Orthopaedic Research Laboratory in University of Helsinki, Finland. This work led to co-founding Askel in 2017 and to an exciting new path in her life. She is one of the founding members, and a long-term Board Member, of the entrepreneurial society of University of Helsinki, Helsinki Think Company. Currently, Virpi serves as the Chairman of the Board of Tissue Cure Alliance Finland and a Member of the Board of the Finnish Research Impact Foundation.
Lauri Paasonen, PhD
Senior scientist UPM Biomedicals, Helsinki
Lauri Paasonen is focusing on 3D cell culture product and application development, and regenerative medicine applications of nanofibrillar cellulose. He has Ph.D. in pharmaceutical sciences from University of Helsinki, Finland, 2010. Before joining UPM on 2014, Lauri worked as a post-doctoral researcher at Sanford-Burnham Medical Research Institute, La Jolla, CA, USA and at the University of Helsinki, Finland.
Emilia Hietala, MSc
Finnadvance, Oulu
Emilia is a young scientist with a M.Sc. in Molecular medicine from University of Oulu, and a research and industry background in developing microphysiological systems for modeling human neurobiology, drug addiction and opioid receptor biology. Her core interests include pre-clinical drug discovery and the pharmaceutical industry, molecular medicine, neurobiology as well as new and innovative technologies. Currently at Finnadvance she is developing brain-on-chip models to combat opioid addiction.
Interested in joining Tissue Cure Alliance Finland?
